MRVI FY 2022 Earnings — Maravai LifeSciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

MRVIMaravai LifeSciences Holdings, Inc.

$999M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$883M+10.5% YoY

Gross Profit

$714M80.9% margin

Operating Income

$574M65.0% margin

Net Income

$220M24.9% margin

EPS (Diluted)

$1.67

Cash Flow

Operating Cash Flow

$536M

Free Cash Flow

$519M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$2.3B

Total Liabilities

$1.4B

Stockholders' Equity

$545M

Cash & Equivalents

$632M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$883M	$799M	+10.5%
Gross Profit	$714M	$659M	+8.4%
Operating Income	$574M	$555M	+3.5%
Net Income	$220M	$182M	+21.0%